Clinical trial
Macugen Observational Study
NCT00735943 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Macugen Observational Study
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Terminated
- Start date
- November 30, 2008
- Completion date
- August 31, 2010
- Enrollment
- 22 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
macular degeneration, vascular endothelial growth factor